Bismuth Subsalicylate 262 Mg Tablet, Chewable
Product Images NDC 69618-029

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bismuth Subsalicylate 262 Mg (NDC 69618-029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Reliable 1 Laboratories Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2e92d053 1618 143b E054 00144ff8d46c

2e92d053 1618 143b E054 00144ff8d46c
BISMUTH SUBSALICYLATE is a chewable tablet containing 262mg of the active ingredient. It's unclear what it is used for as there is no further context provided.*
FDA Label Image

Bismuth (369618029033 Bismuth Subsalicylate Chew Tablets 262 mg)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.